NCT04874350Phase 2Completed

A Study to Assess the Efficacy, Safety, and Tolerability of Oral LPCN 1148 in Male Subjects With Cirrhosis of the Liver and Sarcopenia

Study sponsor: Lipocine Inc. · LPCN

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2023-12-18Actual
Enrollment · participants30Actual
Source updated2024-03-15Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview